Recovery Rheum

Recovery Rheum John D. Carter, MD provides comprehensive rheumatology care for those with autoimmune & inflammatory conditions.

He is a multiple year winner of Tampa’s Best Doctors, Castle Connolly and multiple other patient care awards Carter, MD provides extensive care for those suffering from rheumatic diseases and conditions, including Rheumatoid arthritis, Systemic Lupus Erythematosis (Lupus), Psoriatic arthritis, Ankylosing spondylitis, Inflammatory bowel disease-related arthritis, Non-Radiographic Spondyloarthitis, Gout, Giant cell arteritis (Temporal Arteritis), and Polymyalgia Rheumatica. Prior to Recovery Rheum LLC, Dr. Carter was the former Chief of Rheumatology at USF and Tampa General Hospital for 17 years.

03/27/2026
03/19/2026

Autoimmune fatigue isn’t just “being tired” — it’s a biologic response driven by inflammation. Cytokines like TNF-alpha, IL-1, and IL-6 signal the brain to create “sickness behavior,” while also impairing mitochondria and reducing cellular energy (ATP). Add in autonomic dysfunction affecting blood flow, and it’s no wonder even small tasks feel overwhelming. This is why autoimmune fatigue feels so different — and why understanding the underlying physiology is key to better treatment.

03/14/2026

Autoimmune diseases rarely travel alone. Patients with conditions like rheumatoid arthritis, lupus, thyroid disease, or Sjögren’s often develop more than one autoimmune condition over time—a pattern called polyautoimmunity. Genetics such as certain HLA immune genes, infection-related molecular mimicry, and ongoing immune system dysregulation can all contribute to this process. That’s why when someone has one autoimmune disease, physicians often watch for others. Understanding the bigger immune picture is key to modern autoimmune care.

03/13/2026

Next week will be conducting important research on the healing powers of sand, sun, and Vitamin Sea.

03/08/2026

Many people think of POTS as purely an autonomic nervous system disorder, but research suggests there may be more to the story. Some studies have found that patients with POTS—especially those with hypermobility or Ehlers-Danlos—can have reduced activity in the growth hormone–IGF-1 pathway. Growth hormone helps regulate muscle tone, vascular function, blood volume, and energy metabolism, all systems that can be impaired in POTS. This doesn’t mean low growth hormone causes POTS, and hormone therapy is not standard treatment. But it raises an interesting scientific question: could hormonal signaling play a role in why some patients struggle with severe fatigue, exercise intolerance, and poor muscle support? Understanding that connection could open new areas for research and treatment.

03/05/2026

Ehlers-Danlos Syndrome, or EDS, is a connective tissue disorder that affects collagen — the protein that supports your joints, ligaments, and skin.

Because of this, many patients develop hypermobile joints, chronic pain, frequent injuries, and muscle fatigue, since the muscles have to work overtime to stabilize loose joints.

At Recovery Rheum, we use unique physician-directed approaches designed to improve muscle strength and support while helping reduce inflammation and pain.

With the right strategy, many patients can improve stability and overall quality of life.

02/27/2026

A single fast food meal can trigger inflammation in just 3–5 hours. Here’s how: high saturated fat helps a toxin called LPS — which naturally lives in your gut — slip into your bloodstream. That fat forms transport particles that literally carry LPS across your gut barrier. Once it’s in your blood, your immune system freaks out and releases inflammatory chemicals like TNF-alpha and IL-6. Blood sugar spikes make it worse. One meal won’t ruin you — but if this happens every day, that repeated inflammatory hit adds up fast.

02/26/2026

Short-chain fatty acids—mainly acetate, propionate, and butyrate—are powerful molecules your gut bacteria make when you eat fiber. Short chain fatty acids (SCFAs) can reduce inflammation, regulate the immune system, improve gut barrier health, and may support metabolic health, heart health, liver function, and even brain function. Mechanistically, they influence key pathways like NF-κB, Nrf2, GPR41/43, and HDAC, essentially helping “turn down” inflammatory signals and improve cellular metabolism. But here’s the nuance: effects are dose-dependent and context-specific—some studies show neutral or even mixed effects depending on the person’s metabolic state and the type of SCFA. Bottom line? Fiber feeds your microbiome, your microbiome makes SCFAs, and those metabolites may play a major role in whole-body health—but more high-quality human trials are still needed.

02/25/2026

If you want to naturally boost short-chain fatty acids (SCFAs) in your gut, focus on a high-fiber, plant-forward diet that feeds your good bacteria. SCFAs are produced when gut microbes ferment fiber, especially prebiotic fibers found in foods like oats, beans, lentils, chickpeas, green bananas, onions, garlic, leeks, asparagus, apples, flaxseeds, and chia seeds. Resistant starch (like cooled potatoes or rice), fermented foods like yogurt and kefir, and a wide variety of colorful vegetables can also help support a thriving microbiome. The key is diversity and consistency — aim to add fiber gradually and drink plenty of water to avoid bloating. That said, everybody’s gut is different, so this type of diet may not be right for everyone — especially if you have digestive conditions — so listen to your body and consider speaking with a healthcare professional.

02/21/2026

Butyrate and propionate are gut-derived short-chain fatty acids (SCFA) involved in immune and inflammatory regulation. Supporting microbiome health through diet and targeted supplementation may help optimize SCFA production. Individual responses vary.

02/20/2026

Flare season, beach season, ANY season — we’ve got you.

02/15/2026

Researchers studied identical twins where only one twin had rheumatoid arthritis. Despite nearly identical genetics and similar overall gut microbiomes, the RA-affected twins showed lower levels of key short-chain fatty acids — butyrate and propionate — along with reduced SCFA-producing bacteria. The same pattern appeared in a UK twin cohort. The takeaway? RA differences may involve microbial metabolism and gut-derived anti-inflammatory compounds, not genetics alone.

Address

2919 W. Swann Avenue, Suite 402
Tampa, FL
33609

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Alerts

Be the first to know and let us send you an email when Recovery Rheum posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category